Digital Could #MedThreads become the new #MedTwitter? Last month, Meta, the tech giant behind Facebook, Instagram, and WhatsApp, announced the launch of Threads: a direct challenger to its now rebranded rival, X (Twitter).
News Zymeworks cuts deal to buy Theravance for $929m in cash Zymeworks has reached a deal to buy Theravance, claiming rights to COPD therapy Yupelri, sold by Viatris, which made $267m last year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.